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INTERMITI'ENT ANTEGRADE 
WARM CARDIOPLEGIA 
REDUCES OXIDATIVE STRESS 
AND IMPROVES 
METABOLISM OF THE 
ISCHEMIC-REPERFUSED 
HUMAN MYOCARDIUM 
The aim of this study was to compare the effect of intermittent antegrade warm blood 
cardioplegia and intermittent antegrade cold blood cardioplegia on myocardial metab- 
olism and free radical generation of the ischemic-reperfused human myocardium. 
Thirty patients undergoing mitral valve procedures were randomly allocated to two 
groups: group 1 (15 patients) received warm blood cardioplegia nd group 2 (15 
paüents), cold blood cardioplegia. Myocardial metabolism was assessed before aortic 
clamping, 1 minute after crossclamp removal, and after 20 minutes of reperfusion, by 
collecting blood simultaneously from the radial artery and coronary sinus. All samples 
were analyzed for lactate, creatine kinase, reduced and oxidized glutathione, ascorbic 
acid, fluorescent products of lipid peroxidation, and leukocyte activation (elastase). In 
all patients, early reperfusion was associated with significant coronary sinns lactate 
release. In group 2, but not in group 1, significant coronary sinus release of reduced and 
oxidized glutathione, fluorescent products of lipid peroxidation, and creatine kinase was 
also found; moreover, arterial-coronary sinus difference of ascorbic acid content was 
increased only in group 2, suggesting a transmyocardial consumption ofthis antioxidant 
vitamin. After 20 minutes of reperfusion, coronary sinus lactate release was no longer 
present in group 1, whereas ignißcant production was still evident in group 2. In this 
group, significant coronary sinus release of fluorescent products of lipoperoxidation a d 
reduced and oxidized glutathione was also observed at this time. No significant release 
of elastase from the coronary sinus was noted in the two groups throughout the study. 
The left ventricular stroke work index measured at the end of the study indicated a 
better functional recovery in group 1 than in group 2. In conclusion, intermittent 
antegrade warm blood cardioplegia protects the myocardinm from ischemia-reperfusion 
injury better than intermittent antegrade cold blood cardioplegia; this phenomenon may 
be partly due to the decreased tissue oxidant burden mediated by intermittent warm 
blood cardioplegia. (J THORAC CARDIOVASC SURG 1995;109:787-95) 
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of ischemic damage, the so-called ischemia-reperfu- 
sion injury. 1 A large body of evidence indicates that 
this injury is mediated by oxygen-derived free radi- 
cals,2, 3 which are maximally produced at the onset 
of myocardial reperfusion and induce biomembrane 
peroxidation.4, 5 Free radical generation and oxida- 
tive stress are evident in the ischemic reperfused 
human myocardium6-9; accordingly, antioxidant ad- 
ministration has been reported to result in a dra- 
matic improvement in postoperative outcome. 1° 
Hypothermia is considered an important ingredi- 
ent during cardioplegic arrest because it slows myo- 
cardial metabolism and reduces ischemia-reperfu- 
sion-induced free radical generation. 1°-12 Recent 
studies, however, have demonstrated myocardial 
depletion of alfa-tochopherol and enhanced coro- 
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Table I. Delivery protocol of  warm intermittent 
antegrade blood cardioplegia 
Flowrates 
Blood K + Duration [K +] * 
Dose (tal/min) (ml/hr) (min) (mEq/L) 
1 300 Push 2 ml, 2 18-20 
then 150 
Following doses at 15 min intervals 
2 200 120 2 20 
3 200 90 2 15 
4 200 60 3 10 
5 200 60 4 10 
6 200 60 5 i0 
*The values are referred to the blood potassium concentration [K--] 
obtained by infusion of potassium at the corresponding flow rates, and they 
are independent on the intrinsic blond potassium values of each patient. 
nary sinus release of lipid peroxides despite cold 
blood cardioplegia. 13 These results suggest hat this 
cardioprotective approach may not afford a "full 
antioxidant" protection for the ischemic-reperfused 
human myocardium. 
Normothermic ardioplegia has been shown to 
yield good metabolic and clinical results) 4-1s In this 
regard, intermittent antegrade warm blood cardio- 
plegia has recently been proposed and standardized 
in a clinical setting as routine myocardial protective 
technique during cardiopulmonary bypass (CPB). 19 
Because normothermic blood cardioplegia results 
in less severe myocardial ischemia-reperfusion in-
jury than cold blood cardioplegia 2°and free radicals 
and oxidative stress are involved in the heart dam- 
age associated with ischemia and reperfusion, 1-1° we 
hypothesized that normothermic blood cardioplegia 
might decrease myocardial oxidant load during isch- 
emia and reperfusion. 
This study was designed to compare the effect of 
intermittent antegrade warm blood cardioplegia nd 
intermittent antegrade cold blood cardioplegia on 
myocardial metabolism and free radical generation 
at reperfusion after cardioplegic arrest. The coro- 
nary sinus levels of fluorescent l ipoperoxidation 
products, reduced and oxidized glutathione (GSH 
and GSSG), and ascorbic acid were used as recog- 
nized indexes of myocardial oxidative stress. 3' 9, 20-22 
Patients and methods 
Thirty patients cheduled for elective mitral valve pro- 
cedures by one surgeon (A.M.C.) agreed to participate in 
a study of alternative cardioplegic techniques. All patients 
signed a consent form approved by the Human Ethical 
Committee of the University of Chieti. 
Surgical technique. CPB was established via two sepa- 
rate venous cannulas, with direct cannulation of the 
superior vena cava. During CPB, hemoglobin value was 
maintained at 6 to 8 gm/dl and pump flow ranged from 2.4 
to 2.8 L/min per square meter. Mean arterial pressure was 
kept at 50 to 60 mm Hg, with the administration ofsodium 
nitroprusside or metaraminol if necessary. The systemic 
temperature was maintained at 37 ° C in the normothermic 
group, whereas patients receiving cold blood cardioplegia 
were cooled systemically to 27 ° C. 
Cardioplegic groups and protoeol for delivery of car- 
dioplegic solution. Patients included in the study were 
randomly allo¢ated to one of two groups" group 1 (15 
patients) received intermittent antegrade warm blood 
cardioplegia nd group 2 (15 patients) received intermit- 
tent  antegrade cold blood cardioplegia. The cardioplegic 
solutions were prepared by mixing blood with potassinm. 
The composition of the cardioplegic solutions was as 
follows (in millimoles per liter): NaC1, 115; KC1, 20; 
MgCI» 15.5; CaCI» 1.3; NaHCO» 12; and tromethamine, 
4. 
In group 1 (warm blood cardioplegia), blood was taken 
directly from the oxygenator by a x/4-in¢h tubing and was 
infused at 37 ° C into the aortic root by means of a roller 
pump. A syringe pump was connected to the V4-in¢h 
tubing to deliver potassium solution. The syringe con- 
tained 50 ml of a solution with 2 mEq of potassium per 
milliliter. The first dose lasted 2 minutes at a flow rate of 
300 tal/min (600 ml overall). The syringe pump rapidly 
pushed 2 ml of the potassinm solution in about 20 
seconds, and then the flow rate was adjusted at 150 tal/min 
for a final concentration of about 20 mEq/L. After ea¢h 
distal anastomosis or after 15 minutes of normothermic 
ischemia, asecond ose was repeated, at a flow rate of 200 
ml/min (blood) and 120 ml/hr (potassium) for 2 minutes. 
Flow rates of blood and potassinm delivery and duration 
of each dose are listed in Table I. 
In group 2 (cold blood cardioplegia), blood was col- 
lected in a cardiotomy reservoir (DIDECO 715, Dideco 
S.P.A., Mirandola, Italy) with a separate heat exchanger 
and a re¢irculating circuit, to maintain a temperature of 
about 8 ° to 10 ° C. 
The first dose was delivered at a flow rate of 300 tal/min 
during 3 minutes (900 ml overall); the longer infusion time 
of the first dose in group 2 (cold blood) as compared with 
group 1 (warm blood) allowed the heart to reach the 
appropriate myocardial temperature (i.e., 8 ° to 10 ° C). 
Further doses were similar to those used in group 1, as 
reported in Table I. In particular, the last dose was always 
comparable for volume but not for temperature (37°C 
versus 8 ° to 10 ° C) to intermittent antegrade warm blood 
cardioplegia. The final volume of cardioplegic solutions 
was similar for the two groups. In any case, reperfusion 
was obtained by removal of the aortic crossclamp in all 
patients. 
The approach to the mitral valve was through the right 
atrium, the interatrial septum, and the roof of the left 
atrinm. Before aortic crossclamping, the right atrinm was 
opened and a soft catheter was introduced into the 
coronary sinus and fixed with a 5-0 Prolene suture (Ethi- 
con, Inc., Somerville, N.J.). 
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Myocardial metabolism was assessed before aortic 
clamping, 1minute after crossclamp removal, and after 20 
minutes of reperfusion by collecting blood simultaneously 
from the radial artery and the coronary sinus. Blood for all 
the determinations, except for GSH and GSSG, was 
collected in brown tubes with heparin and immediately 
centrifuged at 4 ° C; plasma was separated and stored at 
-80 ° C in liquid nitrogen. All samples were analyzed for 
blood gases, pH, lactate, leukocyte activation (elastase), 
creatine kinase (CK), GSH, GSSG, ascorbic acid, and 
lipid peroxides (fluorescent products of lipoperoxidation). 
Measurement of GSI4 and GSSG. GSH and GSSG 
were assessed as previously described. 22 Blood samples 
simultaneously drawn from arterial and coronary sinus 
catheters were immediately divided into separate tubes 
containing GSH and GSSG collection buffer. GSH collec- 
tion buffer consisted of 0.5 ml of potassium phosphate 
buffer (0.1 mol/L), pH 7.4, 5,5'-dithiobis(2-nitrobenzoic 
acid) (3 mmol/L), and ethylenediaminetetraacetic acid (5 
mmol/L). Supernatants for GSH were immediately frozen 
at -70 ° C for subsequent analysis. 
GSSG collection buffer consisted of 0.3 ml of potassium 
phosphate buffer (0.1 mol/L), pH 6.5, with N-ethylmale- 
imide (10 mmol/L) and 5 ethylenediaminetetraacetic acid 
(5 mmol/L). N-ethylmaleimide r acts with reduced sulf- 
hydryl groups (such as GSH) and prevents their detection 
in the assay of GSSG. Supernatants for GSSG analysis 
were then processed to remove excess N-ethylmaleimide, 
as previously described. 22 An adaptation of the assay 
devised by Tietze 23 and modified by Adams, Lauterburg, 
and Mitchell z4 was used to measure GSH and GSSG. 
Grossly hemolyzed samples occurred rarely and were 
discarded. The possibility of minor hemolysis was checked 
by procedures capable of detecting 0.2% free hemoglo- 
binY Experiments to assess efficiency of recovery were 
performed by adding known amounts of GSH (10 to 100 
nmol/ml) and GSSG (0.5 to 5 nmol/ml) to plasma samples. 
Recoveries of GSH and GSSG were excellent. Results are 
expressed as nanomoles per deciliter. 
Ascorbic acid assay. Ascorbic acid content in plasma 
was assessed as previously describedY In brief, 2 ml of 
trichloroacetic acid (0.615 mol/L) was added to 1 ml of 
plasma. After 5 minutes of preincubation at room tem- 
perature, the mixture was centrifuged at 2000 rpm for 10 
minutes. Then, to 1 ml of this supernatant was added 2.5 
ml of a solution containing 2,4,6-tripyridyl-s-triazine (0.24 
mmol/L) and iron chloride (80 ~mol/L) in sodium acetate 
buffer plus 20% methanol (vol/vol), pH 5.9. Absorbance 
values at 595 nm were then recorded on a double-beam 
Varian DMS 200 spectrophotometer (Varian Techtron 
Pty, Ltd., Melbourne, Australia) against an appropriate 
blank. Results were expressed as micromoles of vitamin C 
per liter. 
Fluorescent produets of lipid peroxidation. Lipid per- 
oxidation was evaluated via assessment of fluorescent 
damage products of lipid peroxidation, which essentially 
reflect the interaction of peroxidation aldehydes with 
phospholipids. 27
Total lipid was extracted from plasma as previously 
describedY The lipid-containing phase was removed and 
the samples were dried under a stream of nitrogen gas at 
room temperature) 8 The dried samples were resus- 
pended in chloroform. To 1 ml of the chloroform layer 0.1 
ml of methanol was added and the fluorescence values 
were estimated spectrofluorometrically t 360 and 430 nm 
excitation and emission, 27' 28 respectively, with a Kontron 
SFM25 spectrofluorometer (Kontron Instruments, Inc., 
Everett, Mass.) calibrated with quinine sulfate. The re- 
sults were expressed as units of relative fluorescence per 
milliliter of plasma. 
Lactate assay. Blood samples for lactate concentration 
were mixed with a measured volume of 6% perchloric 
acid. Lactate concentration was determined in the pro- 
tein-free supernatant by an enzymatic method. The results 
were expressed in millimoles per liter. 
CK and elastase. Serum CKwas analyzed by a standard 
spectrophotometric method. Leukocyte activation was 
assessed by measuring elastase levels by an immunoacti- 
vation assay 16 (Merck-Clévenot, Chelles, France). 
Hemodynamic measurements. Hemodynamic data 
were obtained by a radial arterial catheter and a ther- 
mistor-tipped pulmonary catheter (Swan-Ganz model 
93A-831H-7.5F, Baxter Healthcare Corp., Edwards Div., 
Irvine, Calif.). Pulmonary capillary wedge pressure, radial 
artery pressure, and cardiac output were recorded. The 
cardiac index and left ventricular stroke work index were 
calculated. 29The hemodynamic parameters were mea- 
sured before the operation and 20 minutes after the end 
of CPB. Until this time, no patients received inotropic or 
vasoactive drugs. 
Statistical analysis. Data are expressed as mean _+ 
standard error of the mean, unless otherwise indicated; 
statistical significance was assumed at a probability level 
of less than 0.05. Differences in hemodynamic parameters 
within the groups were tested by paired Student's t test. 
An analysis of variance for repeated measures was used to 
test the effects of cardioplegia on biochemical parameters; 
when analysis of variance indieated a difference at the 5% 
level or less, Scheff6's test was used for individual group 
comparisons. Differences between the two groups were 
tested by unpaired Student's t test. 
Results 
The ¢linical profiles are presented in Table II. 
The two groups were not significantly different 
regarding age, sex, and CPB time. The aortic cross- 
clamping time was slightly longer in the warm blood 
than in the cold blood cardioplegia group. This 
difference was not statistically significant, although 
we cannot exclude that with a larger database a 
significant trend could have been obtained. How- 
ever, the metabolic differences observed between 
the two groups are striking and not an expression of  
a mere trend. Cold cardioplegic solution was deliv- 
ered during 12.6% _+ 1.05% of the crossclamping 
period, and warm cardioplegic solution was infused 
during 9.5% +- 0.83% of the crossclamping interval 
(p = 0.025). This difference was essentially related 
to the longer infusion time of the first dose of cold 
cardioplegic solution; the shorter ischemic time in 
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Table II. Summary of clinical data 
Group 1 Group 2 p Value 
Patients (n) 15 15 NA 
Age (yr) 63 ± 12.8 69 + 4.7 NS 
Sex (M/F) 8/7 9/6 NA 
NYHA class 8/6/1 8/5/2 NA 
(ii/iiHv) 
CPB time (min) 76.4 ± 9.6 83 ± 18.6 NS 
Aortic clamping 56.5 + 8.7 62.5 ± 16 NS 
time (min) 
Data are shown as mean -+ standard eviation of the mean; group 1, wann 
intermittent antegrade blood cardioplegia; group 2, cold intermittent 
antegrade blood cardioplegia; NYHA, New York Heart Association; NA, 
statistics not applicable; NS, not significant. 
the warm than in the cold blood group, although not 
statistically significant (Table II), could have con- 
tributed to the aforementioned difference. 
Hemodynamic parameters for both groups before 
and after CPB are reported in Table III. No signif- 
icant change in hemodynamic parameters was ob- 
served in group 1 (warm blood cardioplegia), 
whereas significantly lower left ventricular stroke 
work index (34.4 _ 2.6 versus 43.2 _ 2.3 gm x 
m/m2,p = 0.017) was found in group 2 at 20 minutes 
after the end of CPB as compared with before 
crossclamping. Even though the measurement of 
left ventricular stroke work index appears to be load 
dependent, 15no patients received inotropic or vaso- 
active drugs until the hemodynamic study; more- 
over, as shown in Table III, the levels of mean 
arterial pressure (expression of afterload) and of 
pulmonary capillary wedge pressure (which may be 
considered an expression of preload) were not sig- 
nificantly different between the two groups. 
Metabolie data 
Changes in plasma glutathione levels. In both 
groups arterial GSH levels remained stable during 
the reperfusion period. No significant changes in 
coronary sinus concentrations of GSH and GSSG 
were observed in group i throughout reperfusion. In 
contrast, a marked and significant coronary sinus 
release (Fig. 1) of both GSH and GSSG was found 
in group 2 (-161 + 19 nmol/dl,p < 0.0001; -23.9 + 
3.3 nmol/dl, p < 0.0001, respectively). In this group, 
the arterial-coronary sinus differences for GSH and 
GSSG were still negative after 20 minutes of reper- 
fusion (-75 _+ 14 nmol/dl, p < 0.0001; -14.6 + 1.7 
nmol/dl, p < 0.0001, respectively). 
Fluorescent products of lipid peroxidation. Fig. 2 
shows the mean values of arterial-coronary sinus 
differences for fluorescent lipoperoxidation prod- 
uets. At 1 minute after crosselamp removal, coro- 
Table III. Summary of hemodynamic data of 30 
patients before and at the end of CPB* 
Before After p 
CPB CPB Value 
Group 1 
HR (beats/min) 76 - 7 87 ± 7 NS 
CI (L/min per square 2.70 --_ 0.27 2.96 ± 0.14 NS 
meter) 
MAP (mm Hg) 80 ± 8 75 ± 4 NS 
PCWP (mm Hg) 11.4 ± 1.9 9.4 --- 1.4 NS 
LVSWI (gm- m/m 2) 44.6 -+ 3.6 40 ± 6.5 NS 
Group 2 
HR (beats/min) 74 ± 5 82 - 4 NS 
CI (L/min per square 2.68 ± 0.21 2.35 -+ 0.15 NS 
meter) 
MAP (mm Hg) 86 -+ 5 89 ± 7 NS 
PCWP (mm Hg) 10.5 --- 1.6 12.2 ± 1.8 NS 
LVSWI (gm. m/m 2) 43.2 ± 2.3 34.4 ± 2.6 0.017 
*Data are shown as means -+ standard error of the mean; group 1, wann 
intermittent antegrade blood cardioplegia; group 2, cold intermittent 
antegrade blood cardioplegia; HR, heart rate; C1, cardiac index; MAP, 
mean arterial pressure; PCWP, pulrnonary capillary wedge pressure; 
LVSWI, left ventricular stroke work index; NS, not significant. 
nary sinus concentrations of fluorescent lipoperoxi- 
dation products were significantly higher than the 
arterial evels in group 2 (p < 0.0001), whereas no 
significant difference was found in group 1. At 20 
minutes of reperfusion, the concentrations were still 
significantly higher in the coronary sinus than in the 
arterial blood (p < 0.0001). On the contrary, no 
significant arterial-coronary sinus difference was 
found in group 1. 
Ascorbic acid levels.Arterial levels of ascorbic acid 
did not change significantly throughout the study. In 
group 1, levels of ascorbic acid in the coronary sinus 
were not significantly different from arterial concen- 
trations. Conversely, a significant increase in arteri- 
al-coronary sinus difference (Fig. 2) was found in 
group 2 after release of the crossclamp with respect 
to baseline (from 0.41 _ 0.3 txmol/L to 4.35 ___ 0.5 
~mol/L, p < 0.0001). In this group, ascorbic acid 
level was still significantly lower in the coronary 
sinus than in the artery at 20 minutes of reperfusion 
(p < 0.0001). 
Lactate, CK and elastase plasma levels. A signifi- 
cant release of lactate from the coronary sinus 
occurred in both groups 1 minute after unctamping 
(Fig. 3); this release was significantly higher in group 
1 than in group 2 (p < 0.05). After 20 minutes of 
reperfusion, a significant myocardial lactate produc- 
tion was still present in group 2, but lactate release 
was completely reversed to extraction i  group 1. No 
significant changes in CK arterial-coronary sinus 
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Fig. 1. Time course of changes in arterial-coronary sinus 
differences ofplasma GSH and GSSG. Data are expressed 
as means + standard error of the mean. PreXCl, Before 
aortic crossclamping; XCl-off, 1 minute after crossclamp 
removal, Rep, after 20 minutes of reperfusion; L4WBC, 
intermittent antegrade warm blood cardioplegia; IACBC, 
intermittent antegrade cold blood cardioplegia. 
differences were found throughout he study in 
group 1 (Fig. 3), whereas a significant CK release 
was observed in group 2 at 1 minute after unclamp- 
ing; the release was markedly reduced but still 
significant at 20 minutes of reperfusion. As shown in 
Fig. 4, arterial elastase levels increased over time in 
both groups. This increase was significantly higher 
in group 2 than in group 1 throughout reperfusion. 
However, coronary sinus elastase values were not 
significantly different from arterial evels in either 
group throughout the study. 
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Fig. 2. Time course of changes in arterial-coronary sinus 
differences ofplasma fluorescent products of lipid peroxi- 
dation (FPL) and ascorbic acid. Data are expressed as 
means _+ standard error of the mean. PreXCI, Before 
aortic cross-clamping; XCl-off, 1 minute after crossclamp 
removal; Rep, after 20 minutes of reperfusion;/AWBC, 
intermittent antegrade warm blood cardioplegia; IACBC, 
intermittent antegrade cold blood cardioplegia. 
Discussion 
Our data suggest that oxidative stress is avoided in 
hearts protected by intermittent antegrade warm 
blood cardioplegia. In fact, in group 1 coronary 
sinus concentrations of GSH, GSSG, and fluores- 
cent lipoperoxidation products never exceeded arte- 
rial levels (see Figs. 1 and 2) throughout the reper- 
fusion period, a finding that seems to rule out the 
occurrence of myocardial oxidative stress. On the 
contrary, a significant coronary sinus release of 
GSH, GSSG, and fluores¢ent lipoperoxidation 
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minute after crossclamp removal; Rep, after 20 minutes of 
reperfusion; L4WBC, intermittent antegrade warm blood 
cardioplegia; IACBC, intermittent antegrade cold blood 
cardioplegia. 
products (see Figs. 1 and 2) was present in group 2 
during reperfusion. These data are indicative of 
myocardial oxidative stress and myocyte biomem- 
brane alterations. 3'9'2°-22 However, some differ- 
ences observed between the two groups may be 
partly related to a potentially lower coronary flow in 
the patients treated by cold blood cardioplegia 
(group 2), presumably as a result of cold-induced 
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Fig. 4. Time course of changes in arterial and coronary 
sinus elastase concentration (leukocyte aetivation). Data 
are expressed as means -+ standard error of the mean. 
PreXCl, Before aortic crossclamping; XCl-off, 1 minute 
after crossclamp removal; Rep, after 20 minutes of reper- 
fusion;Ao, aorta; Cs, coronary sinus; IAWBC, intermittent 
antegrade warm blood cardioplegia; IACBC, intermittent 
antegrade cold blood cardioplegia. 
coronary constriction. The loss of cellular GSH 
represents an important rate-limiting factor for the 
reaction involved in cell detoxification from oxygen- 
reactive intermediates. 3°' 31 Moreover, the increased 
myocardial production and release of GSSG, caused 
by cellular incapability to regenerate GSH from its 
oxidized form, is considered a sensitive and specific 
index of intracellular oxidative stress. 3'9, 22, 30, 31 
Thus in group 2 the readmission of normothermic 
fully oxygenated blood at reperfusion seems to favor 
the shifting of the oxidation-reduction state of the 
cells toward oxidation, resulting in free radical- 
mediated cellular damage. 
Accordingly, in this group ascorbic acid content 
was always significantly lower in the coronary sinus 
than in the arterial blood during reperfusion, sug- 
gesting a transmyocardial consumption of this vita- 
min (see Fig. 2). In contrast, no significant difference 
between coronary sinus and arterial concentrations 
of this antioxidant was evidenced in group 1 
throughout the study. 
Ascorbic acid represents the outstanding antioxi- 
dant in the plasma environment, 32 whereas the 
antioxidant properties of vitamin E are essentially 
operative at biomembrane l vel. 33 Indeed, free radi- 
cal-driven plasma peroxidation begins only when 
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vitamin C is depleted, even though vitamin E is still 
present at high concentrations. 34 
Reportedly, the most important sources of free 
radicals in the myoeardial cell are represented by 
the mitochondrial electron transport system, the 
arachidonic pathway and activated neutrophil, or, in 
some species, xanthine oxidase. 1-3 However, xan- 
thine oxidase activity is not present in homogenates 
of the whole human heart, 35 although the enzyme 
seems to be localized at the capillary endothelium 
level of human myocardium. 36This finding could 
explain the beneficial effect of allopurinol in de- 
creasing oxidative stress in human hearts, although 
both a metabolic action and direct free-radical scav- 
enging properties of the drug and its metabolite, 
oxypurinol, may be operative. 37'3b In out study 
leukocyte activation was assessed by the release of 
elastase, which is a protease stored in azurophilic 
granules of polymorphonuclear leukocytes. 39 Ac- 
cording to previous studies, 4°'41 a significant in- 
crease in elastase arterial evels was found at reper- 
fusion in both groups (Fig. 4). However, the absence 
of significant ransmyocardial e astase production 
seems to rule out the possible role of an increased 
neutrophil activation within the myocardium. It has 
recently been reported that hypothermia may in- 
duce a significant mitochondrial dysfunction at the 
level of the electron transport chain. 42'43 After 
release of the crossclamp, the reperfusion of the 
cold ischemic myocardium with almost normother- 
mic fully oxygenated blood, in the presence of a 
depressed mitochondrial function, may result in an 
increased cellular oxidative burden. 
The data also show that warm rather than cold 
cardioplegia better protects the heart from isch- 
emia-reperfusion injury. Accordingly, the absence of 
a significant CK coronary sinus release in group 1 
(see Fig. 3) during the reperfusion confirms the 
hypothesis of a more effective protection given by 
warm cardioplegia. In group 2, the reperfusion- 
induced release of CK and GSH reflects both in- 
ereased cellular membrane permeability and dam- 
age. The finding that in group 1 coronary sinus 
lactate release was limited to the immediate pos- 
treperfusion period (see Fig. 3), whereas in group 2 
lactate myocardial production persisted uring the 
entire reperfusion period, is consistent with a more 
rapid recovery of aerobic metabolism in the hearts 
protected by warm eardioplegia. In these hearts the 
coronary sinus lactate release, at the time of aortic 
crossclamp release, largely reflects the washout of 
the metabolite accumulated during CPB rather than 
a continued anaerobic myocardial activity. More- 
over, the higher lactate washout at reperfusion in 
group 1 than in group 2 could be an expression of a 
more elevated glycolytic activity and anaerobic pro- 
duction of adenosine triphosphate. In this regard, it 
is worth noting that glycolytic adenosine triphos- 
phate is considered relevant for membrane function 
and integrity, 44'45 so that this mechanism could 
contribute to the cardioprotective effect of intermit- 
tent antegrade warm blood cardioplegia. Further- 
more, free radicals or GSSG have been shown to 
inhibit the oxidative metabolism of lactate. 46 Thus, 
prevention of oxidative stress by intermittent ante- 
grade warm blood cardioplegia may, in turn, favor a 
more rapid recovery of myocardial aerobic metabo- 
lism at reperfusion. 
Antioxidant repairing mechanisms, uch as regen- 
eration of GSH, are energy-dependent phenome- 
na.3, 3o It has recently been demonstrated that nor- 
mothermia increases myocardial oxygen delivery 
and consumption during cardioplegia nd reperfu- 
sion, favoring mitochondrial oxidative phosphoryla- 
tion and adenosine triphosphate r generation from 
adenosine diphosphate and monophosphate. 2°' 47 In 
contrast, hypothermia seems to alter tissue oxygen 
delivery and reduce the cell's ability to produce 
adenosine triphosphate etficiently after a period of 
anaerobic arrest. 1s'2° Furthermore, it is widely 
known that the activities of many enzymes involved 
in crucial metabolic pathways uch as glycolysis or 
free radical detoxification are inhibited by low tissue 
temperatures.18, 42 Finally, the superiority of warm 
as compared with cold blood cardioplegia in pro- 
tecting the myocardium during CPB is further sup- 
ported by hemodynamic data showing a better fune- 
tional recovery in group 1 than in group 2. 
In conclusion, intermittent antegrade warm blood 
cardioplegia provides bettet metabolic and func- 
tional recovery for the ischemic-reperfused human 
myocardium than does intermittent antegrade cold 
blood cardioplegia. This effect may be partly related 
to a decreased myocardial oxidant burden. 
We acknowledge Professor Carmine Di Ilio for help 
and advice with the data analysis. We thank Domenico De 
Cesare for his skillful technical assistance and Franca 
Daniele, MD, for her help in preparing the manuscript. 
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